CAS 67579-24-2

rel-4-Bromo-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]benzamide

Description:

Rel-4-Bromo-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]benzamide, with the CAS number 67579-24-2, is a chemical compound characterized by its unique structural features, including a bromine atom and a dimethylamino group attached to a cyclohexyl moiety. This compound belongs to the class of amides and is notable for its potential biological activity, which may include interactions with specific receptors or enzymes in biological systems. The presence of the bromine atom can influence its lipophilicity and reactivity, while the dimethylamino group may enhance its pharmacological properties. The stereochemistry indicated by the (1R,2R) configuration suggests specific spatial arrangements that can affect the compound's interaction with biological targets. As with many organic compounds, its solubility, stability, and reactivity can vary based on environmental conditions such as pH and temperature. Overall, this compound is of interest in medicinal chemistry and pharmacology, potentially serving as a lead compound for further drug development.

Formula: C₁₅H₂₁BrN₂O

InChI: InChI=1/C15H21BrN2O/c1-18(2)14-6-4-3-5-13(14)17-15(19)11-7-9-12(16)10-8-11/h7-10,13-14H,3-6H2,1-2H3,(H,17,19)/t13-,14-/m0/s1

InChI key: InChIKey=UFDJFJYMMIZKLG-ZCWZLOQUNA-N

SMILES: N(C(=O)C1=CC=C(Br)C=C1)[C@H]2[C@H](N(C)C)CCCC2

Synonyms:

• 4-Bromo-N-(trans-2-(dimethylamino)cyclohexyl)benzamide
• 4-bromo-N-[(1S,2S)-2-(dimethylamino)cyclohexyl]benzamide
• Benzamide, 4-bromo-N-(2-(dimethylamino)cyclohexyl)-, trans-
• Benzamide, 4-bromo-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-, rel-
• Bromadolina
• Bromadolina [Spanish]
• Bromadoline [INN]
• Bromadolinum
• Bromadolinum [Latin]
• U 4793e
• Unii-R8Dwn01P1M
• rel-4-Bromo-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]benzamide
• trans-p-Bromo-N-(2-(dimethylamino)cyclohexyl)benzamide
• Bromadoline
• 81447-81-6 (Maleate)
• Bromadoline, U-47931E

Bromadoline

Controlled Product

CAS: 67579-24-2

Bromadoline is a fatty acid that is used as a pharmaceutical preparation, and can be administered orally in solid form. It inhibits the activity of the transporter gene associated with the production of fatty acids, and has been shown to inhibit the activity of fatty acid synthesis in cells. Bromadoline has been shown to have an inhibitory effect on fatty acid production in cultured human liver cells, and was also found to inhibit the accumulation of triglycerides in rat adipocytes. This drug may be useful for diagnosis of conditions such as obesity and diabetes. Bromadoline binds to specific receptors on cells that are responsible for fat absorption and transport, which may contribute to its therapeutic effects.

Formula: C₁₅H₂₁BrN₂O

Purity: Min. 95%

Molecular weight: 325.24 g/mol

Ref: 3D-SCA57924

Bromadoline

CAS: 67579-24-2

Bromadoline is an opioid compound that exhibits anti-nociceptive properties in rodents.

Formula: C₁₅H₂₁BrN₂O

Color and Shape: Solid

Molecular weight: 325.244

Ref: TM-T204210